Washington. Scientists have developed a chemical compound that they say can prevent infection with the SARS-CoV-2 virus or reduce the severity of COVID-19 if given early in the course of infection. could.
According to researchers at the University of Washington School of Medicine in the US, a compound called ‘MM3122’ weakens them by interfering with a key feature of several viruses attacking human cells. The compound, reported in the journal Proceedings of the National Academy of Sciences, targets transmembrane serine protease 2 (TMPRSS2), a key protein found in humans, which is also used by the coronavirus to enter and kill human cells. To infect.
Study author James W. Janetka, a professor at the University of Washington, said, “While many vaccines against SARS-CoV-2 now exist, there is still a need for effective ‘antiviral’ drugs to reduce the severity of this global pandemic.” needed.”
“The chemical compound we are developing will prevent the virus from entering the cells,” he said. Janetka said the goal of the study is to develop the molecules into an inhibitor that can be taken by mouth and could become an effective part of anti-Covid-19 drug inhibitors.